The Dublin-based Botox-maker Allergan announced early Wednesday it would abandon its mega-merger with U.S. phamaceutical giant Pfizer after new government regulations made the tax advantage of the cross-Atlantic deal more difficult to achieve.
The move is a huge victory for the Obama administration in its campaign against inversions, in which U.S.-based companies buy or merge with a smaller foreign firm and move their headquarters overseas in order to lower their tax bill. The Treasury Department released new regulations Monday to stem th...
22:56 Yahoo says Verizon buyout delayed but still on20
21:52 Netflix nears 94 million subscribers 10 years after streaming launch21
22:33 Allergan to pay $15 million over failing to disclose merger talks19
18:21 Mark Zuckerberg takes the stand in $2 billion lawsuit claiming Oculus theft16